Synthesis of new dihydropyrimidine derivatives and investigation of their antimicrobial and DNA gyrase inhibitory activities
Archiv der Pharmazie · 2025-01 · 358 (1)
DOI: 10.1002/ardp.202400795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 21.01.2025. Verfasst von Asaf Evrim Evren und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey. Hauptthemen laut MEDLINE: Topoisomerase II Inhibitors, Anti-Bacterial Agents, DNA Gyrase, Pyrimidines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anadolu University Scientific Research Projects.
Abstract (Originalsprache)
Quinolone antibiotics are known for their antibacterial activity by inhibiting the enzyme DNA gyrase. Inspired by their mechanism, new compounds combining 1,4‐dihydropyrimidine, a quinolone isostere, with pyridine/pyrimidine rings were synthesized. These derivatives showed antibacterial effects, likely through DNA gyrase inhibition, as supported by molecular docking and dynamics simulations. The synthesized compounds, 2‐[(5‐cyano‐6‐oxo‐6‐(pyridin‐4‐yl)‐1,6‐dihydropyrimidin‐2‐yl]‐ N ‐(benzothiazol‐2‐yl)‐acetamide ( 5a–5g ) and 2‐[(5‐cyano‐6‐oxo‐6‐(pyridin‐4‐yl)‐1,6‐dihydropyrimidin‐2‐yl)thio]‐ N ‐(thiazol‐2‐yl)acetamide ( 6a–6f ), were evaluated for antibacterial activity. Compounds 5a , 6b , and 6c demonstrated significant bactericidal effects. Against Escherichia coli , compounds 6b and 6c exhibited minimum inhibitory concentration (MIC) values of 1.95 and 0.97 µg/mL, respectively, comparable to the standard drug. Compound 5a also showed strong activity against Escherichia faecalis . DNA gyrase inhibition studies confirmed that 5a , 6b , and 6c inhibit the enzyme, as no supercoiled DNA band was observed. These findings highlight the potential of these compounds as antibacterial agents. Future development could focus on optimizing these structures for enhanced activity, similar to quinolone antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
- Department of Pharmacy Services, Vocational School of Health Services, Bilecik Şeyh Edebali University, Bilecik, Turkey.
- Faculty of Pharmacy, University for Business and Technology, Prishtina, Kosovo.
- Department of Pharmacy, Faculty of Medical Sciences, Thamar University, Dhamar, Yemen.
- Department of Pharmacy, Faculty of Medical Sciences, Al-Hikma University, Dhamar, Yemen.
- Department of Pharmacy Services, Pazaryeri Vocational School of Health, Bilecik Şeyh Edebali University, Pazaryeri, Bilecik, Turkey.
ORCID-Profile: Demokrat Nuha
Förderung
- Anadolu University Scientific Research Projects
Zitieren
APA
Evren, A. E., Nuha, D., Dawbaa, S., Kayış, U., Gül, Ü. D., & Yurttaş, L. (2025). Synthesis of new dihydropyrimidine derivatives and investigation of their antimicrobial and DNA gyrase inhibitory activities. Archiv der Pharmazie, 358(1). https://doi.org/10.1002/ardp.202400795
Vancouver
Evren AE, Nuha D, Dawbaa S, Kayış U, Gül ÜD, Yurttaş L. Synthesis of new dihydropyrimidine derivatives and investigation of their antimicrobial and DNA gyrase inhibitory activities. Archiv der Pharmazie. 2025;358(1). doi:10.1002/ardp.202400795
BibTeX
@article{Evren2025,
author = {Evren, Asaf Evrim and Nuha, Demokrat and Dawbaa, Sam and Kayış, Uğur and Gül, Ülküye Dudu and Yurttaş, Leyla},
title = {Synthesis of new dihydropyrimidine derivatives and investigation of their antimicrobial and DNA gyrase inhibitory activities},
journal = {Archiv der Pharmazie},
year = {2025},
volume = {358},
number = {1},
doi = {10.1002/ardp.202400795}
}
EUVIMED